Abstract
Recombinant DNA technology has opened up a novel field for the agricultural biotechnologists to explore and design custom-made crops with specific trait(s). In addition to enhancing yield, transgenic plants are designed to have enhanced defense against pathogens, remove toxic compounds from the soil, to be tolerant to environmental stresses, to be live bioreactors to produce pharmaceuticals, to have improved nutritional features reflecting changes in protein, oil or vitamin content or to have woody species with lower generation time. But all plants with novel characters come with a price. The objective of the article is to evaluate the utility of the transgenic plants with respect to their novel features, the economic implications, seed security, agricultural sustainability and food safety. The gene mapping program of Arabidopsis and rice gives rise to the ethical question of the commercial patentability of the bioengineered plants. The impact of this science on agriculture that is being faced by the world with special reference to the developing countries of Asia is being discussed.
Keywords: Arabidopsis, Agrobacterium, DISEASE, Bacillus thuringensis, (Cydia pomonella), (Ostrinia nubilalis), (Leptinotarsa decemlineata)., Photorhabdus lumnescens, Ustilago maydis, Halobacterium halobium
Current Genomics
Title: Bioengineered Crops: The Commercial and Ethical Considerations
Volume: 2 Issue: 2
Author(s): Susmita Sengupta, L. K. Sengupta and P. S. Bisen
Affiliation:
Keywords: Arabidopsis, Agrobacterium, DISEASE, Bacillus thuringensis, (Cydia pomonella), (Ostrinia nubilalis), (Leptinotarsa decemlineata)., Photorhabdus lumnescens, Ustilago maydis, Halobacterium halobium
Abstract: Recombinant DNA technology has opened up a novel field for the agricultural biotechnologists to explore and design custom-made crops with specific trait(s). In addition to enhancing yield, transgenic plants are designed to have enhanced defense against pathogens, remove toxic compounds from the soil, to be tolerant to environmental stresses, to be live bioreactors to produce pharmaceuticals, to have improved nutritional features reflecting changes in protein, oil or vitamin content or to have woody species with lower generation time. But all plants with novel characters come with a price. The objective of the article is to evaluate the utility of the transgenic plants with respect to their novel features, the economic implications, seed security, agricultural sustainability and food safety. The gene mapping program of Arabidopsis and rice gives rise to the ethical question of the commercial patentability of the bioengineered plants. The impact of this science on agriculture that is being faced by the world with special reference to the developing countries of Asia is being discussed.
Export Options
About this article
Cite this article as:
Sengupta Susmita, Sengupta K. L. and Bisen S. P., Bioengineered Crops: The Commercial and Ethical Considerations, Current Genomics 2001; 2 (2) . https://dx.doi.org/10.2174/1389202013351011
DOI https://dx.doi.org/10.2174/1389202013351011 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fluorescent Dyes for Bio-Applications in the Patent Literature
Recent Patents on Materials Science Eating Green: Shining Light on the Use of Dietary Phytochemicals as a Modern Approach in the Prevention and Treatment of Head and Neck Cancers
Current Topics in Medicinal Chemistry Wnt Signaling in Liver Cancer
Current Drug Targets Growth Inhibition of Human Non-Small Lung Cancer Cells H460 By Green Tea and Ginger Polyphenols
Anti-Cancer Agents in Medicinal Chemistry Targeting DNA Minor Groove by Hybrid Molecules as Anticancer Agents
Current Medicinal Chemistry Statins and Cancer
Anti-Cancer Agents in Medicinal Chemistry Pharmacogenetics of Drug Transporters
Current Pharmaceutical Design Mechanisms of Cancer Prevention by Green and Black Tea Polyphenols
Anti-Cancer Agents in Medicinal Chemistry Macroautophagy as a Target of Cancer Therapy
Current Cancer Therapy Reviews New Anti-Angiogenic Targeted Therapy in Advanced Renal Cell Carcinoma (RCC):Current Status and Future Prospects
Reviews on Recent Clinical Trials Targeted Therapies in Bone Sarcomas
Current Cancer Drug Targets Radiative Effects on Boundary-Layer Flow of a Nanofluid on a Continuously Moving or Fixed Permeable Surface
Recent Patents on Mechanical Engineering Emerging Role of the Ubiquitin-proteasome System as Drug Targets
Current Pharmaceutical Design Recent Development of Drug Delivery Systems for the Treatment of Asthma and Related Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Treatment Strategies for Multiple Myeloma in the Age of Novel Therapies
Current Cancer Therapy Reviews Archaeosome Immunostimulatory Vaccine Delivery System
Current Drug Delivery Anti-cancer Effects of Curcumin on Head and Neck Cancers
Anti-Cancer Agents in Medicinal Chemistry Mesenchymal stem cell therapy for inflammatory bowel diseases: promise and challenge
Current Stem Cell Research & Therapy SPECT-CT in Radiotherapy Planning, with Main Reference to Patients with Breast Cancer
Current Radiopharmaceuticals Chemical Structure and Surface Modification of Dendritic Nanomaterials Tailored for Therapeutic and Diagnostic Applications
Current Topics in Medicinal Chemistry